January 27th, 2023
This conference has already taken place.
Description
The field of hematology is rapidly changing and new data is published year round. This new data is practice changing and needs to be incorporated into clinical practice. The target audience does not have the time needed to attend the meeting and to analyze the large amount of data presented and therefore is unable to incorporate new discoveries and recent changes in treatments presented during the national ASH meeting to their clinical practice. Due to these issues, the target audience is not able to stay up to date.
For pricing information, see pricing tab below.
Dates and Times
Start: 1/27/2023 12:00 AM
End: 1/27/2023 12:00 AM
Objectives
- Explain the updates in lymphoma, chronic lymphocytic leukemia, multiple myeloma, MDS, AML, MPNs, and benign hematology, and employ the knowledge gained to improve patient care
- Discuss the changing therapeutic landscape of malignant and benign hematology and how it applies to the clinical practice
- Review the early phase clinical trial data and how it may translate to the management of hematologic disorders
Agenda
Ohio State’s 2023 ASH Review
Friday, January 27
7 a.m. - 1:00 p.m. Fawcett Event Center
7 am. Registration and Breakfast
8 a.m. Welcome and Overview
Srinivas Devarakonda, MDAssociate Professor, Division of Hematology OSUCCC – James
Narendranath Epperla, MD, MS
Assistant Professor, Division of Hematology OSUCCC – James
SESSION I
8:05 a.m. Lymphoma
Tim Voorhees, MD
Assistant Professor, Division of Hematology OSUCCC – James
8:25 a.m. Chronic Lymphocytic Leukemia
Seema A. Bhat, MD
Associate Professor, Division of Hematology OSUCCC – James
8:45 a.m. Multiple Myeloma
Elvira Umyarova, MD
Assistant Professor, Division of Hematology OSUCCC – James
9:05 a.m. Live Q&A
9:15 a.m. Break
SESSION II:
9:35 a.m. MDS and AML
Kieran Sahasrabudhe, MD
Assistant Professor, Division of Hematology OSUCCC – James
9:55 a.m. Myeloproliferative Neoplasms
Jennifer Vaughn, MD
Assistant Professor, Division of Hematology OSUCCC – James
10:15 a.m. Benign Hematology
Spero Cataland, MD
Professor, Division of Hematology OSUCCC – James
10:35 a.m. Live Q&A
SESSION III
10:45 a.m. Allo SCT
Gabriella Sanchez Pettito, MD
Assistant Professor, Division of Hematology OSUCCC – James
11:05 a.m. Live Q&A
11:15 a.m. Break
11:45 a.m. Michael R. Grever, MD, Distinguished Professor Lectureship
Marcos De Lima, MD
Professor, Division of Hematology
Director, Blood and Bone Marrow Transplant and Cellular Therapy Program OSUCCC – James
12:45 p.m. Live Q&A
1:00 p.m. Lunch and Adjourn
Pricing
| Tier | Price |
|---|---|
| This is a Free Event | $0.00 |
Location
The Fawcett Center
2400 Olentangy River Rd
Columbus, OH 43210
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure
Dr. Srinivas Devarakonda, Dr. Narendranath Epperla, Dr. Timothy Voorhees, Dr. Seema Bhat, Dr. Elvira Umyarova, Dr. Kieran Sahasrabudhe, Dr. Jennifer Vaughn, Dr. Spero Cataland, Dr. Gabriela Sanchez-Petito, Prof. Marcos de Lima, the faculty, the planners, the reviewers, and the CME provider have no relevant financial relationship with a commercial interest (defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients), that relates to the content that will be discussed in the educational activity.